Paeds Flashcards
Which infants should routinely be referred for US for DDH?
Child hip problem in 1st-deg relative
Breech >= 36 wk
Multiple pregnancy
Barlow and Ortolani tests done when?
Newborn check
6-8 week check
Investigation of suspected DDH with US hips at age
<4.5 months old
Investigation of suspected DDH with Xray at age:
> 4.5 months old
Management of DDH with Pavlov harness at age:
<5 months old
Management of DDH with surgery at age:
> 5 months old
Neonatal blood spot screening (‘Guthrie’/’heel-prick’) is performed at..
Day 5-9 of life
Neonatal blood spot screens for..
Congenital hypothyroidism
Cystic fibrosis
Sickle cell disease
Phenylketonuria
Medium chain acyl-CoA dehydrogenase deficiency (MCADD)
Maple syrup urine disease (MSUD)
Isovaleric acidaemia (IVA)
Glutaric aciduria type 1 (GA1)
Homocystinuria (HCU)
Precocious puberty in females
Secondary sexual characteristics <8 yrs
Precocious puberty in males
Secondary sexual characteristics <9yrs
5-16y asthma - Newly-diagnosed with symptoms <3/week + no nocturnal waking
SABA reliever therapy alone
(salbutamol)
5-16y asthma - Newly-diagnosed with symptoms >=3/week +/- nocturnal waking
SABA + paediatric low-dose ICS
(<=200 mcg budesonide/equiv)
5-16y asthma -
Not controlled on:
SABA alone
SABA + paediatric low-dose ICS
(<=200 mcg budesonide/equiv)
5-16y asthma -
Not controlled on:
SABA + paediatric low dose ICS
SABA + paediatric low-dose ICS + LTRA
5-16y asthma -
Not controlled on:
SABA + paediatric low dose ICS + LTRA
Stop LTRA
SABA + paediatric low-dose ICS + LABA
5-16y asthma -
Not controlled on:
SABA + paediatric low-dose ICS + LABA
SABA + MART [paediatric low-dose ICS + LABA]
5-16y asthma -
Not controlled on:
SABA + MART [paediatric low-dose ICS + LABA]
SABA + MART [paediatric moderate-dose ICS + LABA]
or
SABA + paediatric moderate-dose ICS + LABA
5-16y asthma -
Not controlled on:
SABA + moderate-dose ICS + LABA
(fixed-dose or MART)
Paediatric high-dose ICS (MART/separate)
or
Theophylline/Expert advice
Refer for unilateral undescended testes - at what age?
3 months
Management of bilateral undescended testes
Same-day paediatrician review
Occurrence of undescended testis in newborn term male
2-3%
Croup - features prompting admission
Moderate/severe
<6m
Known upper airway abnormality
Uncertain diagnosis
Management of mild croup
Stat dose PO dexamethasone 150mcg/kg
Management of scarlet fever
PO Penicillin V QDS for 10/7
Notify PHE
Management of Scarlet Fever (pen-allergic)
Azithromycin OD for 5/7
Management of impetigo
Fusidic acid 2% TDS 5 days
Presentation of Measles
Irritable febrile prodrome
Conjunctivitis
Koplik spots
Rash behind ears > confluent
Classic presentation of Rubella
Maculopapular rash, from face -> whole body
Postauricular + suboccipital LN
Classic presentation of Mumps
Fever
Earache + pain on eating (unilateral -> bilateral)
Presentation of Erythema Infectiousum
(Fifth-disease/Slapped-cheek/Parvovirus B19)
Fever
Headache + lethargy
Rash from cheeks -> upper arms.
Scarlet fever - features
(Group A haemolytic strep toxins)
Fever
Tonsillitis
Strawberry tongue
Sandpaper rash + Circumoral pallor
HFM disease presentation
(Cocksackie A16 virus)
Vesicles in mouth + palms + soles
Fever, sore throat
Bed-wetting is considered normal up to age.
Age 5
Short-term management of bed-wetting in >7yr old (eg school trip)
Desmopression
Limit fluid 1hr pre - 8hr post
Incidence of cleft lip/palate
1 / 1000
Cleft lip usually repaired when
1 week - 3 months
Cleft palate usually repaired when
6 months - 1 year
Presentation of missed DDH in an older child
Trendelenberg gait + leg length discrepancy
1st-line management of CMPA
Formula-fed
Mild/moderate
eHF (extensive hydrolysed formula)
Management of CMPA
Formula-fed
Severe/2nd-line
AAF (amino acid-based formula)
1st-line management of CMPA- breast-fed
Maternal cows milk elimination
Calcium + vit D supplement
eHF milk after weaning
Pertussis vaccine in pregnancy
All offered 16-32 wks
Management of pertussis
>6 months old
Macrolide (if within 21 days onset)
Prophylactic antibiotics for household
Notify PHE
Complications of pertussis
Apnoea
Pneumonia, Bronchiectasis
Seizures
Subconjunctival haemorrhage, petechiae
Incidence of DDH
1 - 3%
(20% of which are bilateral)
Features of congenital Rubella
Sensorineural deafness
Congenital cataracts
Pyloric stenosis age of presentation
2wk - 6wk (rarely up to 4 months)
Definitive management of pyloric stenosis
Pyloromyotomy (Ramstedt or laparoscopic)
Presentation of pyloric stenosis
Projectile vomits 30min after feed
Upper abdominal mass
Constipation, dehydration, alkalosis
Chance of Down’s syndrome child - at maternal age 35
1 in 270
Chance of Down’s syndrome child - at maternal age 20
1 in 1,500
Chance of Down’s syndrome child - at maternal age 30
1 in 800
Chance of Down’s syndrome child - at maternal age 40
1 in 100
Chance of Down’s syndrome child - at maternal age 50
> =1 in 50
Investigation used to diagnose vesicoureteric reflux (VUR)
Micturating cystourethrogram